Ivabradine in the Acute Management of Cardiogenic Shock
NCT07714746
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Cardiogenic Shock Post Myocardial Infarction
Interventions
DRUG:
Ivabradine 5mg Tab
DRUG:
Placebo Oral Tablet
Sponsor
National Institute of Cardiovascular Diseases, Pakistan